Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT-1 (Investigation of Methylone for PTSD)
2023-505874-14-00Phase 2Completed
- Sponsor
- Transcend Therapeutics
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of methylone in post-traumatic stress disorder (PTSD) (3 arms), sponsored by Transcend Therapeutics. Started Sep 2023; status: completed.
02
Drugs
methylone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2023-505874-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505874-14-00.